Literature DB >> 21732732

Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study.

Eleni Georgoulopoulou1, Marco Vinceti, Francesca Bonvicini, Patrizia Sola, Carlo Alberto Goldoni, Gianfranco De Girolamo, Diana Ferraro, Paolo Nichelli, Jessica Mandrioli.   

Abstract

We performed a prospective population-based study to describe the temporal pattern of the incidence and prevalence and the clinical features and phenotypes of ALS in Modena, Italy, from 2000 to 2009. From 2000 onwards, a prospective registry has been collecting all cases of incident ALS among residents in the province of Modena. This source was implemented by cases resulting from the provincial hospitals, and by death certificates. Based on 193 newly diagnosed cases, the crude average annual incidence rate of ALS was 2.9 cases per 100,000 person years (py); adjusted incidence rate was 2.8/100,000. The age-standardized incidence rates increased from 2.6 per 100,000 py in 2000-2004 to 2.9 per 100,000 py in 2005-2009, representing an annual increase of approximately 2% throughout the 10-year period. There was a constant increase in prevalence rates throughout the years of the study (from 5.8/100,000 on 31 December 2000 to 11.2/100,000 on 31 December 2009). Median life time was 29 months for patients diagnosed before the year 2000 and 36 months for patients diagnosed from 1 January 2000 (p < 0.01). Thus, we report incidence rates similar to those reported by recent European population based studies, but we observed an increasing trend over the 10 years of the study. The increasing incidence is not explained by aging of the population, and our study raises the question as to whether local environmental or genetic factors are driving this temporal trend. Along with an increasing incidence, we found an important increase in prevalence and survival probably related to access to mutidisciplinary clinics and improvements in symptomatic care of ALS.

Entities:  

Mesh:

Year:  2011        PMID: 21732732     DOI: 10.3109/17482968.2011.593037

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  11 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

2.  Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.

Authors:  Marco Vinceti; Tommaso Filippini; Jessica Mandrioli; Federica Violi; Annalisa Bargellini; Jennifer Weuve; Nicola Fini; Peter Grill; Bernhard Michalke
Journal:  J Trace Elem Med Biol       Date:  2017-01-03       Impact factor: 3.849

3.  Changing epidemiology of motor neurone disease in Scotland.

Authors:  Danielle J Leighton; Judith Newton; Laura J Stephenson; Shuna Colville; Richard Davenport; George Gorrie; Ian Morrison; Robert Swingler; Siddharthan Chandran; Suvankar Pal
Journal:  J Neurol       Date:  2019-02-25       Impact factor: 4.849

4.  Factors predicting survival in ALS: a multicenter Italian study.

Authors:  Andrea Calvo; Cristina Moglia; Christian Lunetta; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialo; Gianni Sorarù; Francesca Trojsi; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Adriano Chiò; Valeria Ada Sansone; Gabriele Mora; Vincenzo Silani; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Maria Rosaria Monsurrò; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Nicola Fini; Jessica Mandrioli
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

5.  Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.

Authors:  Adriano Chiò; Gabriele Mora; Cristina Moglia; Umberto Manera; Antonio Canosa; Stefania Cammarosano; Antonio Ilardi; Davide Bertuzzo; Enrica Bersano; Paolo Cugnasco; Maurizio Grassano; Fabrizio Pisano; Letizia Mazzini; Andrea Calvo
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

Review 6.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

7.  Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Authors:  Marco Vinceti; Nikolay Solovyev; Jessica Mandrioli; Catherine M Crespi; Francesca Bonvicini; Elisa Arcolin; Eleni Georgoulopoulou; Bernhard Michalke
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

8.  Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence.

Authors:  Katy Tobin; Mark S Gilthorpe; James Rooney; Mark Heverin; Alice Vajda; Anthony Staines; Orla Hardiman
Journal:  J Neurol       Date:  2016-07-02       Impact factor: 4.849

9.  Prevalence of amyotrophic lateral sclerosis in Latium region, Italy.

Authors:  Maria Puopolo; Ilaria Bacigalupo; Paola Piscopo; Eleonora Lacorte; Alessandra Di Pucchio; Marialaura Santarelli; Maurizio Inghilleri; Antonio Petrucci; Mario Sabatelli; Nicola Vanacore
Journal:  Brain Behav       Date:  2021-10-30       Impact factor: 2.708

Review 10.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.